Conference - Boston, MA, United States
Ophthalmological pharmacology has historically lacked systematic understanding of disease mechanisms, especially of those for the back of the eye. This is now changing with the discovery of novel targets and pathways paired with a greater understanding of the role of genetics in ocular pathologies. The third annual Targeting Ocular Disorders will cover some of the most promising emerging therapies in the treatment of ocular diseases. Special focus with be given to age-related macular degeneration and retinopathy. Designated sessions will emphasize the role of precise imaging techniques and animal models in accelerating preclinical development. Recent solutions in drug delivery to the back of the eye will also be discussed.
Organization: Cambridge Healthtech Institute (CHI)
For more information, please visit: http://www.healthtech.com/targeting-ocular-disorders/
22 September, 2015 - 23 September, 2015 (10:00 - 18:00)
Westin Boston Waterfront Hotel
Boston, MA 02109, United States
Contact: Kerri Kelley (chi@healthtech.com)
Phone: 7819725400
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
